HLB Pharmaceutical Co. Ltd (047920) — Working Capital to Net Assets Ratio
HLB Pharmaceutical Co. Ltd (047920) has a Working Capital to Net Assets ratio of 33.5% as of September 2025. Working capital of ₩40.46 Billion (current assets of ₩83.17 Billion minus current liabilities of ₩42.70 Billion) is measured against net assets of ₩120.95 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See HLB Pharmaceutical Co. Ltd net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
HLB Pharmaceutical Co. Ltd Working Capital to Net Assets (2014–2024)
This chart shows how HLB Pharmaceutical Co. Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 33.5%, reflecting working capital of ₩40.46 Billion against net assets of ₩120.95 Billion KRW. Check 047920 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for HLB Pharmaceutical Co. Ltd (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for HLB Pharmaceutical Co. Ltd from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is HLB Pharmaceutical Co. Ltd worth.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 21.3% | ₩24.75 Billion | ₩116.40 Billion | ₩63.38 Billion | ₩38.63 Billion | ▼ -4.5 pp |
| 2023 | 25.7% | ₩22.68 Billion | ₩88.15 Billion | ₩71.57 Billion | ₩48.90 Billion | ▲ +17.5 pp |
| 2022 | 8.2% | ₩7.09 Billion | ₩85.93 Billion | ₩59.95 Billion | ₩52.86 Billion | ▲ +0.6 pp |
| 2021 | 7.6% | ₩5.96 Billion | ₩78.38 Billion | ₩51.47 Billion | ₩45.51 Billion | ▼ -66.3 pp |
| 2020 | 73.9% | ₩33.00 Billion | ₩44.62 Billion | ₩94.98 Billion | ₩61.98 Billion | ▲ +39.8 pp |
| 2019 | 34.1% | ₩5.93 Billion | ₩17.36 Billion | ₩29.02 Billion | ₩23.09 Billion | ▲ +4.4 pp |
| 2018 | 29.7% | ₩5.05 Billion | ₩17.00 Billion | ₩21.28 Billion | ₩16.22 Billion | ▼ -3.2 pp |
| 2017 | 32.9% | ₩5.53 Billion | ₩16.80 Billion | ₩23.27 Billion | ₩17.74 Billion | ▼ -59.7 pp |
| 2016 | 92.6% | ₩17.50 Billion | ₩18.90 Billion | ₩24.36 Billion | ₩6.86 Billion | ▲ +26.1 pp |
| 2015 | 66.5% | ₩8.10 Billion | ₩12.18 Billion | ₩15.05 Billion | ₩6.96 Billion | ▲ +32.0 pp |
| 2014 | 34.4% | ₩1.66 Billion | ₩4.81 Billion | ₩13.36 Billion | ₩11.70 Billion | — |